Quantcast

EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone

February 26, 2009

VIENNA, Austria and CUXHAVEN, Germany, February 26 /PRNewswire/ –
EUCODIS Bioscience, a company developing proteins for the chemical industry,
and Lohmann Animal Health (LAH), a company developing and marketing products
for animal nutrition and animal health, today announced the achievement of a
major development milestone in their collaboration agreement relating to the
optimization of an undisclosed protein.

EUCODIS Bioscience has completed the development of the prototype protein
which is intended to be part of an innovative LAH product. This achievement
triggered a milestone payment to EUCODIS Bioscience from LAH. The development
project has moved into its final phase, with LAH testing the protein in the
field.

“The achievement of this milestone underlines the capacity of EUCODIS
Bioscience to develop enzymes and other proteins for different industrial
applications”, said Rudy Pandjaitan, PhD, CEO EUCODIS Bioscience. “Together
with the upcoming launch of our first commercial enzyme, this achievement
further fuels our efforts to aggressively expand our current European focus
into the US and Asian markets.”

“We are pleased to work with a development partner such as EUCODIS
Bioscience that combines industrial discipline with a versatile and proven
technology”, said Dr. Bruno Kaesler, Managing Director of LAH. “Using their
protein know-how and development expertise improves the R&D efficiency of LAH
and helps us to provide superior products to our customers”.

About Lohmann Animal Health

Lohmann Animal Health (LAH) is a leading provider of feed components and
vaccines for farm animals, contributing to a safe food supply. Based in
Germany, LAH is active in major markets worldwide, with more than 70 percent
of its revenues generated from export sales. The Company has more than 500
employees in Germany and the United States as well as in its subsidiaries and
sales offices in over 30 countries.

As European market leader LAH offers a wide variety of proven and
innovative products in the Feed Additives segment. They range from amino
acids and antioxidants to flavors and colorants to probiotics and enzymes.
LAH also offers the entire spectrum of vitamins and provitamins, including
beta-carotene, as well as specialties such as L-carnitine and botanicals.

For more information, please visit http://www.lah.de

About EUCODIS Bioscience

EUCODIS Bioscience GmbH develops enzymes and other proteins and related
biocatalytic processes that enable the chemical, pharmaceutical and other
industries to establish critical manufacturing processes and to generate
superior products.

Based on its proven proprietary technology and led by an experienced
management team, EUCODIS Bioscience provides products and services that help
its customers to improve efficiencies and to meet growing environmental
requirements.

The Company commercializes its enzyme expertise and its versatile and
powerful technology in development projects with industrial partners. Current
partners include industry leaders such as GlaxoSmithKline, Henkel, and
Lohmann Animal Health.

The Company was founded in 2007, as a demerger of the “white biotech”
business unit of Eucodis GmbH, a company founded in 2004. The Company is
headquartered in Austria, Europe, with subsidiaries in France and Germany.

    For more information, please visit http://www.eucodisbioscience.com

    Contact Lohmann Animal Health:
    Dr. Roland Boerner
    Head of Corporate Communications
    Lohmann Animal Health GmbH & Co KG
    Heinz-Lohmann-Strasse 4
    D-27472 Cuxhaven
    Germany
    +49-4721-747-424
    Roland.Boerner@lah.de

    Company contact EUCODIS Bioscience:
    Rudy Pandjaitan, PhD
    CEO EUCODIS Bioscience
    Brunner Strasse 59
    A-1230 Vienna
    AUSTRIA
    +43-1-86634-9241
    office@eucodisbioscience.com

    Media contact EUCODIS Bioscience:
    Frank Butschbacher
    Investor Relations & Communications

http://www.butschbacher.net

    +43-650-7844940
    office@butschbacher.net

SOURCE EUCODIS Bioscience


Source: newswire



comments powered by Disqus